Larvol Delta - Evaluation-of-the-Safety-Tolerability-and-Reactogenicity-of-the-Baiya-SARSCoV2-Vax-2-Vaccine-for-COVID19-Disease

baiya SARS-CoV-2 Vax 2 - Baiya Phytopharm

http://clinicaltrials.gov/ct2/show/NCT05197712

May 24, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next